Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

25.10
-0.5877-2.29%
Volume:155
Turnover:3.89K
Market Cap:4.02M
PE:- -
High:25.10
Open:25.10
Low:25.10
Close:25.69
52wk High:34.36
52wk Low:19.00
Shares:160.00K
Float Shares:160.00K
Volume Ratio:1.07
T/O Rate:0.10%
Dividend:1.69
Dividend Rate:6.75%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Wegovy Maker Novo Nordisk Lifts Annual Forecast Amid Rising Demand for Weight-Loss Drugs

Deep News
·
Aug 05

Novo Nordisk Raises Earnings Guidance. the Stock Sinks.

Dow Jones
·
Aug 05

Wegovy-Maker Novo Nordisk Raises Full-Year Guidance as Appetite for Weight-Loss Drugs Grows

Dow Jones
·
Aug 05

Novo Nordisk Lifts 2026 Outlook After Strong Q2 Adjusted Results

TIPRANKS
·
Aug 05

Novo Nordisk Q2 Lifts FY Guidance on Stronger GLP-1 Demand

Reuters
·
Aug 05

Novo Nordisk Boosts Adjusted Sales, Operating Profit Guidance for 2026

MT Newswires Live
·
Aug 05

Novo Nordisk reports Q2 adjusted sales DKK 78.49B, up 7% at CER

TIPRANKS
·
Aug 05

Novo Nordisk raises FY26 adjusted sales view to 0% to down 6% from down 4%-12%

TIPRANKS
·
Aug 05

Novo Nordisk Probes Thyroid Cancer Risk in Real‑World GLP‑1 Users

TIPRANKS
·
Aug 05

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Aug 04

Legal Inquiry Launched for Hims & Hers Health Following Share Plunge

Deep News
·
Aug 04

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 04

Novo Nordisk Earnings Seen Lower; Guidance and Wegovy Pill in Focus

Dow Jones
·
Aug 03

Stock Markets Can't Rely on Tech to Power Gains Anymore

Dow Jones
·
Aug 03

Novo Nordisk A/S Expected to Post Earnings of Dkk4.99 a Share - Earnings Preview

Reuters
·
Aug 03

Novo Nordisk (NYSE:NVO) Ziltivekimab Trial Fails In Late Stage Cardiovascular Study

Simply Wall St.
·
Aug 02

Is Novo Nordisk Stock (NVO) a Good Buy After Today’s Plunge?

TIPRANKS
·
Aug 01

Exchange Traded Funds Top 10 Percentage Losers

Dow Jones
·
Aug 01

Nasdaq Composite Index Rises 1% as Amazon Surges 15% After Results; Apple and Micron Fall as Memory Stocks Retreat

TradingKey
·
Aug 01

Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback

TIPRANKS
·
Aug 01